Page
%P
-
Article
Trajectory of COVID-19 response and management strategy in China: scientific rationale driven strategy adjustments
The pneumonia caused by novel coronavirus SARS-CoV-2 infection in early December 2019, which was later named coronavirus disease 2019 (COVID-19) by the World Health Organization (WHO), rapidly spread across th...
-
Article
Revisiting China’s response to coronavirus disease 2019
-
Article
Open AccessA nationwide telepathology consultation and quality control program in China: implementation and result analysis
Telepathology may play an important role in pathology consultation and quality control for cancer diagnosis in China, as the country has the largest population of cancer patients worldwide. In 2011, the Pathol...